# Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets

> **NCT01089582** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 628 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT01089582
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 628 (ACTUAL)
- **Last updated:** 2011-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01089582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01089582, "Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01089582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*